Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs

Epilepsy Research

Volumn 96, Issue 3, 2011, Pages 257-266

  Sitges, M ^a   Sanchez Tafolla, B M ^a   Chiu, L M ^a   Aldana, B I ^a   Guarneros, A ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Carbamazepine; Lamotrigine; Oxcarbazepine; Phenytoin; Tetrodotoxin; Topiramate

Indexed keywords

4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; ASPARTIC ACID DERIVATIVE; CALCIUM ION; CARBAMAZEPINE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; POTASSIUM CHANNEL; SODIUM CHANNEL; TETRODOTOXIN; THREO BETA BENZYLOXYASPARTIC ACID; TOPIRAMATE; TRITIUM; UNCLASSIFIED DRUG; VINPOCETINE;

ANIMAL TISSUE; ARTICLE; CHEMICAL LABELING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EXCITABILITY; HIPPOCAMPUS; ION PERMEABILITY; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

4-AMINOPYRIDINE; ANIMALS; ANTICONVULSANTS; CALCIUM; CARBAMAZEPINE; DRUG INTERACTIONS; EPILEPSY; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE ENDINGS; PHENYTOIN; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; SODIUM; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN; TRIAZINES; TRITIUM; VINCA ALKALOIDS;

EID: 80053917195     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.06.006     Document Type: Article

References (25)

1. Ambrosio A.F., Silva A.P., Araujo I., Malva J.O., Soares-da-Silva P., Carvalho A.P., Carvalho C.M. Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels. Eur. J. Pharmacol. 2001, 406:191-201.
2. Armand V., Hoffmann P., Vergnes M., Heinemann U. Epileptiform activity induced by 4-aminopyridine in entorhinal cortex hippocampal slices of rats with a genetically determined absence epilepsy (GAERS). Brain Res. 1999, 841:62-69.
3. Bukanova J., Solntseva E., Skrebitsky V. Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons. Int. J. Neuropsychopharmacol. 2002, 5:229-237.
4. Galván E., Sitges M. Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem. Res. 2004, 29:347-355.
5. Heemskerk F.M., Schrama L.H., Ghijsen W.E., De Graan P.N., Lopes da Silva F.H., Gispen W.H. Presynaptic mechanism of action of 4-aminopyridine: changes in intracellular free Ca2+ concentration and its relationship to B-50 (GAP-43) phosphorylation. J. Neurochem. 1991, 56:1827-1835.
6. Hindmarch I., Fuchs H.H., Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int. Clin. Psychopharmacol. 1991, 6:31-43.
7. Ives A.E., Jefferys J.G. Synchronization of epileptiform bursts induced by 4-aminopyridine in the in vitro hippocampal slice preparation. Neurosci. Lett. 1990, 112:239-245.
8. Morales-Villagran A., Tapia R. Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. Neurochem. Int. 1996, 28:35-40.
9. Nekrassov V., Sitges M. Effects of pentylenetetrazole and 4-aminopyridine on the auditory brainstem response (ABR) and on the hearing sensitivity in the guinea pig in vivo. Epilepsy Res. 2003, 53:245-254.
10. Nekrassov V., Sitges M. Additive effects of antiepileptic drugs and pentylenetetrazole on hearing. Neurosci. Lett. 2006, 406:276-280.
11. Nekrassov V., Sitges M. Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. Clin. Neurophysiol. 2008, 119:2608-2614.
12. Perreault P., Avoli M. Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices. J. Neurophysiol. 1991, 65:771-785.
13. Psarropoulou C., Avoli M. Developmental features of 4-aminopyridine induced epileptogenesis. Brain Res. Dev. 1996, 94:52-59.
14. Rodríguez R., Sitges M. Nigericin-induced Na+/H+ and K +/H+ exchange in synaptosomes: Effect on [3H]GABA release. Neurochem. Res. 1996, 21:889-895.
15. Sitges M., Galindo C. Omega-agatoxin-TK is a useful tool to study P-type Ca2+ channel-mediated changes in internal Ca2+ and glutamate release in depolarised brain nerve terminals. Neurochem. Int. 2005, 46:53-60.
16. Sitges M., Reyes A. Effects of verapamil on the release of different neurotransmitters. J. Neurosci. Res. 1995, 40:613-621.
17. Sitges M., Nekrassov V., Guarneros A. Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings. Brain Res. 2000, 854:48-56.
18. Sitges M., Galvan E., Nekrassov V. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes. Neurochem. Int. 2005, 46:533-540.
19. Sitges M., Chiu L.M., Nekrassov V. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 2007, 52:598-605.
20. Sitges M., Guarneros A., Nekrassov V. Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release. Neuropharmacology 2007, 53:854-862.
21. Sitges M., Aldana B.I., Chiu L.M., Nekrassov V. Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings. Neurochem. Res. 2009, 34:470-479.
22. Tapia R., Sitges M. Effect of 4-aminopyridine on transmitter release in synaptosomes. Brain Res. 1982, 250:291-299.
23. Tibbs G.R., Barrie A.P., Van Mieghem F.J.E., McMahon H.T., Nicholls D.G. Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J. Neurochem. 1989, 53:1693-1699.
24. Yamaguchi S., Rogawski M.A. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 1992, 11:9-16.
25. Zilberter Y.I. One reason for increased seizure susceptibility of hippocampus compared with neocortex. Biochem. (Moscow) Suppl. Ser. A: Membr. Cell Biol. 2007, 1:96-98.